The Wnt/␤-catenin/Tcf and IB/NF-B cascades are independent pathways involved in cell cycle control, cellular differentiation, and inflammation. Constitutive Wnt/␤-catenin signaling occurs in certain cancers from mutation of components of the pathway and from activating growth factor receptors, including RON and MET. The resulting accumulation of cytoplasmic and nuclear ␤-catenin interacts with the Tcf/LEF transcription factors to induce target genes. The IB kinase complex (IKK) that phosphorylates IB contains IKK␣, IKK␤, and IKK␥. Here we show that the cyclin D1 gene functions as a point of convergence between the Wnt/␤-catenin and IB pathways in mitogenic signaling. Mitogenic induction of G 1 -S phase progression and cyclin D1 expression was PI3K dependent, and cyclin D1 Ϫ/Ϫ cells showed reduced PI3K-dependent S-phase entry. PI3K-dependent induction of cyclin D1 was blocked by inhibitors of PI3K/Akt/IB/IKK␣ or ␤-catenin signaling. A single Tcf site in the cyclin D1 promoter was required for induction by PI3K or IKK␣. In IKK␣ Ϫ/Ϫ cells, mitogen-induced DNA synthesis, and expression of Tcf-responsive genes was reduced. Reintroduction of IKK␣ restored normal mitogen induction of cyclin D1 through a Tcf site. In IKK␣ Ϫ/Ϫ cells, ␤-catenin phosphorylation was decreased and purified IKK␣ was sufficient for phosphorylation of ␤-catenin through its N-terminus in vitro. Because IKK␣ but not IKK␤ induced cyclin D1 expression through Tcf activity, these studies indicate that the relative levels of IKK␣ and IKK␤ may alter their substrate and signaling specificities to regulate mitogeninduced DNA synthesis through distinct mechanisms.
INTRODUCTION
The Wingless/Wnt pathway plays a crucial role in development and cell cycle control (Cadigan and Nusse, 1997; Huelsken and Behrens, 2000) . Dysregulation of the Wingless/ (Wnt)/␤-catenin/Tcf pathway has been implicated in tumorigenesis of diverse types (Polakis, 2000a) . Axin/Conductin, together with APC, promote ␤-catenin degradation through serine-threonine phosphorylation of the ␤-catenin N-terminus by GSK3␤, which targets ␤-catenin for ubiquitination by a SCF ␤-TRCP (␤-transducin repeat-containing protein) ubiquitin ligase complex (Fuchs et al., 1999; Winston et al., 1999) and its degradation by the proteasome. On induction of Wnt signaling by extracellular ligands, the Frizzled receptors are activated. The activity of GSK3␤ and its effect on ␤-catenin is antagonized by Dishevelled, a downstream target of Frizzled, thus preventing the degradation of ␤-cate-nin by the proteasome. The resulting accumulation of ␤-catenin leads to its nuclear translocation and binding to Tcf/Lef transcription factors to induce target genes including cyclin D1 and c-Myc (He et al., 1998; Shtutman et al., 1999; Huelsken and Behrens, 2000) .
In addition to components in the Wnt signaling pathway, several other pathways can regulate ␤-catenin/Tcf signaling and gene expression and confer aberrant cellular growth. The protein encoded by Gas6, a growth factor of the vitamin K-dependent family, which binds members of the Axl receptor tyrosine kinase family, stabilizes ␤-catenin, and induces Tcf signaling (Goruppi et al., 2001) . Hepatocyte growth factor/scatter factor (Papkoff and Aikawa, 1998) and oncogenic mutations of RON and MET (Danilkovitch-Miagkova et al., 2001) can also increase cytosolic ␤-catenin and activate Lef/Tcf-responsive reporters. The Xenopus wnt target gene twin is induced by SMAD4 through the ␤-catenin/ Tcf complex (Nishita et al., 2000) . Conversely, genotoxic stress reduces ␤-catenin abundance in part through p53 signaling and a Siah1/Skp1/Ebi complex, which binds the ␤-catenin N-terminus independently of its GSK3␤ phosphorylation sites (Liu et al., 2001; Matsuzawa and Reed, 2001) .
The c-myc and cyclin D1 genes that encode important regulators of cell proliferation have been identified as transcriptional targets of ␤-catenin (He et al., 1998; Shtutman et al., 1999; Tetsu and McCormick, 1999) . Transcription of the cyclin D1 gene is induced through distinct DNA sequences in the promoter by diverse mitogenic and oncogenic signaling pathways including activating mutants of Ras, Src, Stat3, Stat5, and ErbB-2 (Albanese et al., 1995; Bromberg et al., 1999; Matsumura et al., 1999; Pestell et al., 1999; Lee et al., 2000) . Distinct binding sites within the cyclin D1 promoter have been characterized for transcription factors including CREB and AP-1 proteins (Albanese et al., 1995; Watanabe et al., 1996a Watanabe et al., , 1996b Brown et al., 1998) , and a single site at Ϫ81 has shown to bind ␤-catenin/Tcf proteins (Shtutman et al., 1999) . Although Tcf/Lef proteins can function as either enhancer or repressor elements (Bienz, 1998; Barker et al., 2000) , the Tcf binding site of the cyclin D1 promoter at Ϫ81 functioned as an enhancer element that conveyed activation of the cyclin D1 promoter by components of the Wnt/␤-catenin pathway (Shtutman et al., 1999; D'Amico et al., 2000; Lin et al., 2000; Sampson et al., 2001; Soriano et al., 2001) . The cyclin D1 gene encodes a regulatory subunit of the holoenzyme that phosphorylates and inactivates the retinoblastoma (pRB) protein. Homozygous deletion of the cyclin D1 gene in mice demonstrated a requirement for cyclin D1 in normal mammary gland development during pregnancy and mouse embryo fibroblasts (MEFs) derived from the cyclin D1 Ϫ/Ϫ animals have both defective induction of DNA synthesis and enhanced cellular apoptosis rates (Fantl et al., 1995; Sicinski et al., 1995; Albanese et al., 1999; Fantl et al., 1999) . Cyclin D1 overexpression can enhance DNA synthesis, is required for transformation and contact-independent growth in several cell types and has been implicated in several human cancers including breast, colon, and prostate (Shtutman et al., 1999; Tetsu and McCormick, 1999; Lee et al., 2000) . Thus, cyclin D1 plays an important role in tumorigenesis and cell cycle control.
The IB/NF-B pathway is another pathway involved in both cell cycle control and inflammation and has recently been implicated in cancer Yamamoto and Gaynor, 2001 ). The NF-B transcriptional activity is normally inhibited by IB proteins that sequester it in the cytoplasm Joyce et al., 2001) . The IB kinase complex (IKK) that phosphorylates IB contains two functionally distinct kinases, IKK␣ and IKK␤. IKK␤ plays a dominant role in NF-B regulation by TNF-␣ and IL-1 Li et al., 1999a) . In contrast, IKK␣ is required for murine skeletal and keratinocyte differentiation (Li et al., 1999a; Takeda et al., 1999; Hu et al., 2001) . IKK␣ cannot compensate for the loss of IKK␤ (Li et al., 1999a) , suggesting that distinct targets are regulated by IKK␣ and IKK␤. Although the IB/NF-B and Wnt/␤-catenin/Tcf pathways are independent signaling pathways, both IB and ␤-catenin are regulated by phosphorylation at similar consensus N-terminal serines and are targeted for ubiquitination by a similar SCF ␤-TrCP complex followed by proteasomal degradation. The consequences of this regulation are, however, very different (Fuchs et al., 1999; Winston et al., 1999) . Thus, although the SCF ␤-TrCP -mediated degradation of IB leads to the induction of NF-B activity, the SCF ␤-TrCP -mediated degradation of ␤-catenin inhibits the activity of the Wnt pathway. In addition, although GSK3␤ contributes to the degradation of ␤-catenin and represses ␤-catenin/Tcf signaling, the activity of NF-B is enhanced by GSK3␤ (Hoeflich et al., 2000; Polakis, 2000a) .
The IKK complex is regulated by several IKK kinases including the NF-B inducing kinase (NIK), TAK1, MEKK1, Cot/TPL2, and NAK, which coordinate physiological responses to distinct stimuli (Joyce et al., 2001) . NF-B activity is also enhanced by the serine threonine kinase Akt (Madrid et al., 2000; Romashkova and Makarov, 1999) that is known to induce cellular proliferation and survival (Datta et al., 1999) in response to PI3K activation (Franke et al., 1997; Klippel et al., 1998) . Akt is recruited to IKK␣ by stimulation with growth factors, but not by TNF-␣. Akt activation by PI3K is inhibited by the tumor suppressor PTEN, a D3 phosphoinositide phosphatase that induces G 1 arrest in prostate cancer cells (Ramaswamy et al., 1999) , consistent with both a role for PTEN as a prostate cancer cell tumor suppressor and a role of PI3K-Akt activation in cell cycle progression (Di Cristofano et al., 2001) . The Gas6-dependent proliferation and activation of Tcf is also dependent on PI3K (Goruppi et al., 2001) , suggesting a role for PI3K signaling in the regulation of ␤-catenin/Tcf signaling. The components of the cell cycle machinery that are regulated by IKK␣ and are required for PI3K-dependent cellular proliferation, however, remain to be determined.
Here we show a novel role for IKK␣ in mitogenic signaling through transcriptional induction of the cyclin D1 gene. We show that the serum induction of cyclin D1 and G 1 -S phase progression is PI3K-dependent and that cells lacking cyclin D1 show a reduction in PI3K-dependent S-phase entry. PI3K-dependent induction of cyclin D1 was blocked by an inhibitor of IKK␣ and activation of IKK␣-induced cyclin D1. PI3K induction of cyclin D1 was inhibited by a dominant negative Tcf, and a single Tcf site in the cyclin D1 promoter was required for its induction by IKK␣ and PI3K. Mouse embryo fibroblasts derived from mice lacking IKK␣ showed reduced phosphorylation of ␤-catenin and reduced Tcf and cyclin D1 abundance and promoter activity. We had previously shown that IKK␣ exists in a complex with endogenous ␤-catenin (Lamberti et al., 2001 ). Herein we show that purified IKK␣ was sufficient for phosphorylation of ␤-catenin through its N-terminus in vitro, demonstrating that IKK␣ can function as a kinase independently of its heterodimeric partners. Because IKK␣ but not IKK␤ induced cyclin D1 expresion and Tcf activity, these studies indicate that the relative levels of IKK␣ and IKK␤ may alter their substrate and signaling specificities to regulate DNA synthesis through distinct mechanisms.
MATERIALS AND METHODS

Construction of Reporter Genes and Expression Vectors
The human cyclin D1 promoter fragments linked to the luciferase reporter gene in the pA 3 LUC vector promoters of the c-fos gene (c-fosLUC), TOP-FLASH, FOP-FLASH, cyclinELUC, cyclinALUC, c-MycLUC, Engrailed 2 promoter (EngrLUC), 3xRelLUC, and pGL 3 LUC (Promega, Madison, WI) were previously described (He et al., 1998; Joyce et al., 1999; McGrew et al., 1999; D'Amico et al., 2000; Lee et al., 2000) . The expression vectors for p110-K227E, p110-CAAX (Matsumura et al., 1999) , the p110-kinase dead, the p85␣, p85⌬iSH2-N, 85⌬iSH2-C, p85⌬bBCR were kind gifts from Dr. J. Downward (Rodriguez-Viciana et al., 1997) ; pCMV-c-Akt wt, Akt-K179 M, Akt-T308A, were from Dr. A. Bellacosa; and CMV-IB (Super-repressor) [CMV-IB␣ (Sr)] was a gift from Dr. D. Ballard (Brockman et al., 1995) . Mammalian expression vectors for IKK␣ (S176/180E and A) and IKK␤ (S177/181E and A) mutants were provided by Dr. F. Mercurio and for IKK␣ (K54 M) and IKK␤ (K44A) were provided by Tularik Inc (South San Francisco, CA).
Reporter Assays, Cell Culture, and Chemicals
Cell culture and DNA transfection were performed exactly as previously described (Lipofectamine Plus; Life Technologies BRL, Rockville, MD; DiDonato et al., 1997; Zandi et al., 1997) . Transfections were normalized using RSV-␤-gal unless otherwise indicated (DiDonato et al., 1997; Zandi et al., 1997) . The effect of an expression vector was compared with the effect of an equal amount of vector cassette. The DU145 cells were maintained in DMEM with 10% (vol/vol) calf serum and 1% penicillin/streptomycin. SW480 colon cancer cells and Cos-7 kidney cells were grown in DMEM (5% fetal bovine serum). The IKK␣ Ϫ/Ϫ mouse embryo fibroblasts (MEFS) and 3T3 cells were a generous gift from Dr. M. Karin. Cells were plated at ϳ100,000 cells/well in 12-well plates. After 24 h, cells were transfected with the indicated DNA and a Renilla luciferase reporter as an internal control for transfection efficiency. All transfections were done at least in triplicate and were repeated at least three times. Treatments with the PI 3-kinase inhibitor LY294002, the MEK inhibitor PD098059 (10 -20 M), the p38 MAP kinase inhibitor SB203580 (10 -20 M), wortmannin (2, 5, 10 M) were performed for 24 h, and results were compared with vehicle treatment. Luciferase assays were performed at room temperature using an AutoLumat LB 953 (EG&G Berthold, Natick, MA). Luciferase content was measured by calculating the light emitted during the initial 10 s of the reaction, and the values are expressed in arbitrary light units. Statistical analyses were performed using the Mann Whitney U test with significant differences established as p Ͻ 0.05. To select transfected cells, cotransfection experiments were conducted using magnetic separation of transfected cells using CD4 as the marker and the magnetic-activated cell separation system (MACS; Ashton et al., 1999) .
Western Blots and Cell Cycle Analysis
Western blotting was performed with antibodies directed to cyclin D1 (DCS-6; NeoMarkers, Fremont, CA), TFIIB (Transduction Laboratories, Lexington, KY), IKK␣ (mAb was from PharMingen, San Diego, CA), IKK␣, (polyclonal SC7182, Santa Cruz Biotechnology, Santa Cruz, CA) IKK␤, (polyclonal SC7607, Santa Cruz Biotechnology), ␤-catenin (Transduction Laboratories), phospho-␤-catenin (Cell Signaling, Beverly, MA), Flag, (M2, Sigma Chemical Co., St. Louis, MO) and HA (12CA5, Sigma). Cell homogenates (50 g) were electrophoresed in an SDS-12% polyacrylamide gel and transferred electrophoretically to a nitrocellulose membrane (Micron Separations Inc., Westborough, MA). After transfer, the gel was stained with Coomassie blue as a control for blotting efficiency. The blotting membrane was incubated for 2 h at 25°C in T-PBS buffer supplemented with 5% (wt/vol) dry milk to block nonspecific binding sites. After a 6-h incubation with primary antibody at a 1:1000 dilution (cyclin D1) or 1:2500 (␣-tubulin) in T-PBS buffer containing 0.05% (vol/vol) Tween 20, the membrane was washed with the same buffer. For detection of cyclin D1 the membrane was incubated with goat anti-mouse horseradish peroxidase second antibody (Santa Cruz Biotechnology) and washed again. Immunoreactive proteins were visualized by the enhanced chemiluminescence system (Kirkegaard and Perry Laboratories, Gaithersburg, MD). Annexin V staining for apoptosis and cell cycle analysis were performed by flow cytometric analyses using a fluorescenceactivated cell sorter (FACStar plus; Becton Dickinson & Co., Lincoln Park, NJ).
In Vitro Kinase Assays
Kinase assays were performed as described (Yamamoto et al., 2000) . The baculovirus-produced IKK␣ protein was purified by nickelagarose chromatography and then immunoprecipitated with 12CA5 mAb (Yamamoto et al., 2000) . IKK␣ was added to kinase buffer containing 10 Ci of [␥-32 P], 1 mM ATP, 1 mM dithiothreitol, 5 mM MgCl 2 , 100 mM NaCl, 50 mM Tris-HCl, pH 8.0, and then 1 g of each of the substrates including GST-IB␣ (1-54) or GST-␤-cat constructs (Lamberti et al., 2001 ) was incubated for 15 min at 30°C. Reactions were incubated at 30°C for 30 min and stopped by the addition of protein loading buffer and heating to 90°C and SDS-PAGE and autoradiography.
RESULTS
PI3K-induction of Cyclin D1 Requires the Tcf Binding Site
Activation of phosphatidyl inositol 3Ј-kinase (PI3K) mediates signaling induced by a number of growth factors and tumor promoters and is required for mitogenic stimulation by specific growth factors during the G 1 -S phase of the cell cycle (Klippel et al., 1998; Vanhaesebroeck and Waterfield, 1999) . The role of PI3K in serum-induced cyclin D1 expression was examined in mouse embryo fibroblasts (MEFs). In wild-type (wt) MEFs, cyclin D1 protein levels were elevated by 3 h after serum stimulation, and the PI3K inhibitor LY294002 abrogated the induction ( Figure 1A ). Total ERK levels were unchanged under these conditions in both wt and Cyclin D1 Ϫ/Ϫ MEFs ( Figure 1A ). Activity of the fulllength human cyclin D1 promoter linked to a luciferase reporter gene was induced 2.5-fold by serum addition. The PI3K inhibitor reduced serum-induced activation of the cyclin D1 promoter by 80% ( Figure 1B ). Activation of PI3K and Akt plays a key role in DNA synthesis in prostate cancer cells (Ramaswamy et al., 1999; Di Cristofano et al., 2001) . We therefore examined the role of PI3K in the PTEN containing prostate cancer cell line DU145. Because PI3K plays a role in signaling by diverse growth factors, including Gas6 in density-arrested cells (Goruppi et al., 2001) , we examined the regulation of cyclin D1 by PI3K in density-arrested cells. The cyclin D1 promoter (Ϫ1745 CD1LUC) was induced 10-fold by p110␣-CAAX compared with the empty vector ( Figure   1C ). In low-confluence cells the cyclin D1 promoter was induced significantly by p110␣-CAAX in either high ( Figure  1C ) or low serum conditions (2.3-fold Ϯ 0.18, n ϭ 11, p Ͻ Ϫ/Ϫ mice and treated with serum either with or without the PI3K inhibitor LY294002. The Western blot was probed for cyclin D1 and total ERK. (B) The serum-induced activity of the cyclin D1 promoter in the presence or absence of the PI3 kinases inhibitor LY294002 (20 M). (C) DU145 cells at either Ͼ90% or (D) 30% confluence were transfected with a cyclin D1 promoter luciferase reporter plasmid (Ϫ1745CD1LUC) and either the p110␣-CAAX, or (D) the p110␣ kinase dead mutant (p110␣-CAAX-KD) or the constitutively active p110␣-K227E mutant expression plasmid in the presence of either 10% or 0.5% serum. The fold induction of the luciferase reporter activity is shown for nine separate experiments as mean Ϯ SEM throughout. (E) The effect of p110-CAAX on reporter plasmids for cyclin A and the cyclin E promoter, and the luciferase reporter pA 3 LUC. (F) The p110␣-CAAX induction of the cyclin D1 promoter activity was inhibited by LY294002 (using 2, 20, and 100 M). (G) The cyclin D1 promoter activity in the presence of p110␣-CAAX is shown as 100% and is compared with the effect of cotransfected dominant negative inhibitors of PI3K including p85␣, p85⌬iSH2-N, 85⌬iSH2-C, or p85⌬BCR (Rodriguez-Viciana et al., 1997) . The results are shown compared with equal amounts of empty control vector for each expression vector plasmid. 0.01; Figure 1D ). The kinase dead mutant (p110␣-CAAX KD) did not affect cyclin D1 promoter activity, and the constitutively active p110␣-K227E mutant induced cyclin D1 2.2-fold ( Figure 1D ). In contrast with the cyclin D1 promoter, the cyclin E and cyclin A promoters were not induced by p110␣-CAAX ( Figure 1E ), suggesting that the induction of cyclin D1 is not an indirect effect of PI3K activity on DNA synthesis and the effect of p110␣-CAAX is promoter specific. Because cryptic activation sequences, including AP-1, have been identified in several expression vectors, we examined the empty luciferase reporter pA 3 LUC in which the cyclin D1 promoter was cloned and found that pA 3 LUC was not induced ( Figure 1E ) in contrast with pGL 3 LUC, which was induced threefold by p110␣-CAAX (Amanatullah et al., 2001) . Cyclin D1 promoter activation by PI3K was reduced by the chemical inhibitor LY294002 (Figure 1F ) or Wortmannin (our unpublished results). Type 1 PI3K is a heterodimeric holoenzyme, consisting of a regulatory (p85) and a catalytic (p110) subunit, which was initially identified through its role in Src-mediated transformation. p110␣-CAAX induction of cyclin D1 promoter activity was reduced by the previously described dominant inhibitory mutants of the PI3K regulatory subunit (Rodriguez-Viciana et al., 1997; Figure 1G ).
Oncogenic forms of p110␣ and p85 have been identified, and expression of a constitutively active PI3K was shown to trigger DNA synthesis through activation of several distinct signaling pathways (Chang et al., 1997; Klippel et al., 1998) . The cyclin D1 promoter contains several distinct transcription factors binding sites targeted by different signaling pathways (reviewed in Pestell et al., 1999) . Using a series of 5Ј cyclin D1 promoter deletion constructions, the minimal p110␣-CAAX responsive region was identified within the proximal 163 base pairs, which includes a Tcf site at Ϫ81 (our unpublished results). Point mutation of this sequence in the context of the Ϫ1745-base pair promoter fragment abolished induction at either high confluence (Figure 2A ) or at low confluence ( Figure 2B ). p110␣-CAAX induced the Tcf response element (TOP-FLASH) but had no effect on a reporter construct in which the Tcf site fails to bind Tcf/␤-catenin (FOP-FLASH; Figure 2B ). A constitutively active stable mutant of ␤-catenin (␤-catenin Y33), found in colon cancer and the SW48 colon cancer cell line, activates ␤-catenin signaling when transfected into cultured cells. The sequence of the cyclin D1 promoter Tcf site is identical to the canonical sequence of the TOP-FLASH reporter. Consistent with the identification of a single Tcf site in the cyclin D1 promoter required for regulation by ␤-catenin/Tcf signaling in several studies (Shtutman et al., 1999; Lin et al., 2000; Soriano et al., 2001) , the cyclin D1 promoter was induced twofold by ␤-catenin Y33 in DU145 (p Ͻ 0.01, n ϭ 8) and point mutation of the cyclin D1 Tcf site at Ϫ81 abolished induction by both ␤-catenin Y33 and by p110␣-CAAX (Figure 2 , B and C). The twofold induction of Ϫ1745CD1LUC by ␤-catenin Y33 in DU145 is consistent with the threefold induction of cyclin D1 promoter activity described in Hela cells (Tetsu and McCormick, 1999) .
To investigate the signaling pathways by which PI3K induced cyclin D1, we used previously well-characterized dominant negative mutant expression vectors. In agreement with a previous study in which expression of Rac1-N17 blocked PI3K-induced activity (Rodriguez-Viciana et al., 1997) , p110-CAAX-induced cyclin D1 promoter activity was reduced 50% by Rac1-N17 ( Figure 2D ). Because PI3K activates Akt (Franke et al., 1995; King et al., 1997) , we examined the role of Akt in PI3K induction of cyclin D1. A kinaseinactive dominant negative Akt (Akt K179 M), but not wildtype Akt, inhibited p110␣-CAAX-induced activation of cyclin D1 ( Figure 2D ). Because Akt regulates several distinct pathways including NF-B activity (Kane et al., 1999; Romashkova and Makarov, 1999) , we examined the possibility that IKK activity may play a role in PI3K induction of cyclin D1. The dominant IB inhibitor, CMV-IB␣Sr, inhibited p110␣-CAAX-induced activation of cyclin D1 ( Figure 2D ) but did not inhibit c-fos LUC activity (our unpublished results). The p38 MAPK inhibitor SB203580, the ERK inhibitor PD98059, and rapamycin had no effect on p110␣-induced D1 activity (our unpublished results). Tcfs may serve as either activators or repressors of gene transcription through the Tcf site (Bienz, 1998; Barker et al., 2000) . In DU145 cells we found that mutation of the cyclin D1 Tcf site reduced the basal promoter activity to 55%, consistent with previous studies suggesting the cyclin D1 Tcf site functions as a basal enhancer element in several cell types (Shtutman et al., 1999; D'Amico et al., 2000; Soriano et al., 2001 ; Figure 2E ). Coexpression of a DN-Tcf, but not wild-type Tcf, inhibited p110-CAAX induced cyclin D1 promoter activity ( Figure 2F ). Together these studies suggest p110-CAAX induction of cyclin D1 promoter activity involves a Tcf signaling pathway.
Cyclin D1 Is Required for PI3K-dependent S-Phase Entry in Primary Cells
The current studies suggest cyclin D1 is a distal target of PI3K in serum-induced DNA synthesis. Cyclin D1 is known to play a role in the entry of cells into the DNA synthetic (S) phase induced by several growth factors and mitogens. The role of PI3K in serum-induced DNA synthesis through cyclin D1 is not known and was therefore further examined. In wt MEFs, serum-induced entry into S phase, increased from 10 to 26% ( Figure 3A) . LY294002 reduced the S-phase proportion from 26 to 7% at 24 h, indicating that serum-induced DNA synthesis is substantially PI3K dependent in MEFs (Figure 3, A and B) . LY294002 treatment reduced seruminduced DNA synthesis by a mean of 39% at 12 h after serum addition but did not affect the serum-induced entry into the S-phase fraction in the cyclin D1 Ϫ/Ϫ MEFs ( Figure  3C , mean for n ϭ 4 separate experiments). To confirm that LY294002 was effective at inhibiting signaling downstream of PI3K in both the cyclin D1 wt and cyclin D1 Ϫ/Ϫ MEFs, western blotting was performed for phosphorylated Akt using a specific antibody, and the membrane was probed for total ERK as a control ( Figure 3D ). Serum-induced phosphorylation of Akt was reduced by LY294002 in both cell types ( Figure 3D ). Similar analyses of serum-induced DNA synthesis were performed in 3T3 cells derived from the cyclin D1 ϩ/ϩ and cyclin D1 Ϫ/Ϫ MEFs with similar results (our unpublished results). To determine the role of PI3K in apoptosis mediated by serum deprivation, annexin V staining and sub G 1 analysis was performed on the MEFs. Cyclin D1 Ϫ/Ϫ MEFs exhibited a fivefold greater level of annexin V staining compared with wt MEFs, indicating increased basal apoptosis as previously shown that was rescued by serum ( Figure 3E ). LY294002 did not affect the level of apoptosis in either wt or cyclin D1 Ϫ/Ϫ MEFs as determined by either annexin V staining (Figure 3E ) or sub G 1 analysis (our unpublished results). These studies suggest that a substantial component of serum-induced expression of cyclin D1 is PI3K dependent and that MEFs derived from animals deleted of the cyclin D1 gene show reduced PI3K-dependent induction of DNA synthesis.
IKK␣, but not IKK␤ Induces Cyclin D1 through ␤-Catenin/Tcf
The studies described above indicate that the PI3K activation of cyclin D1 involves Akt and IB (Ozes et al., 1999) . As IKKs regulate IB activity, we assessed the role of IKKs in PI3K-dependent activation of cyclin D1 using previously characterized dominant negative IKK mutants . These expression vectors behaved as previously described in cultured cells (below). We found that both the dominant negative and kinase dead IKK␣ constructs reduced PI3K-induced cyclin D1 promoter activity and the basal promoter activity in a dose-dependent manner ( Figure  4A ). The constitutively active mutant IKK␣CA(S176/180E) induced the cyclin D1 promoter 4.2-fold ( Figure 4B ). The IKK␣CA expression vector was previously well characterized and was shown to integrate in the IKK kinase using the identical transfection approach (DiDonato et al., 1997; Zandi et al., 1997) . In contrast with IKK␣, the constitutively active IKK␤ mutant (IKK␤CA) decreased the cyclin D1 promoter activity (see below). Using a series of 5Ј promoter deletion constructions the IKK␣ responsiveness was confined to the proximal Ϫ163 base pairs (our unpublished results). Mutation of the Tcf site in the context of the Ϫ1745-base pair fragment abolished induction of cyclin D1 by IKK␣CA (Figure 4C) . IKK␣CA induced TOP-FLASH threefold but did not induce a reporter with mutations of the Tcf site (FOP-LUC; Figure 4C ). IKK␣CA also activated the canonical NF-Bresponsive sequences (3xRelLUC) to the same extent ( Figure  4C ). Consistent with previous studies, in which PI3K and Akt induced NFB activity in response to IL-1 (Madrid et al., 2000 (Madrid et al., , 2001 , the IKK␣ kinase dead and dominant negative mutants reduced the activity of the NFB-responsive reporter gene 3XRelLUC in the presence of p110␣-CAAX (Figure 4D ). To provide genetic evidence for the involvement of IKK␣ activity in regulating cyclin D1, MEFs from IKK␣ Ϫ/Ϫ mice were selected by the 3T3 protocol. Cells were serum starved for 24 h and western blotting was performed to determine cyclin D1 levels. Immunostaining for IKK␣ showed the pres- Figure 5A ). We found that cyclin D1 abundance was reduced by 85% in the IKK␣ Ϫ/Ϫ cells ( Figure  5A ), and the activity of the cyclin D1 promoter in the IKK␣ Ϫ/Ϫ cells was lower by 67% compared with IKK␣ ϩ/ϩ cells ( Figure 5B ). Serum treatment induced cyclin D1 abundance in wt MEFs by two-to threefold after 3 h, whereas in the IKK␣ Ϫ/Ϫ cells, induction was delayed until 6 h after serum stimulation ( Figure 5C ), suggesting a role for IKK␣ in both the basal level of cyclin D1 expression and in seruminduced cyclin D1 abundance. Because IKK␣ induced cyclin D1 through the Tcf site and serum-induction of cyclin D1 protein abundance was defective in the IKK␣ Ϫ/Ϫ cells, we assessed the role of the cyclin D1 promoter Tcf site in seruminduced activity. In wt 3T3 cells, serum-induced activation of the cyclin D1 promoter was reduced more than 90% by mutation of the Tcf site ( Figure 5D ). Furthermore, seruminduced activation of the cyclin D1 promoter was defective in the IKK␣ Ϫ/Ϫ cells ( Figure 5D ). Consistent with the reduced abundance of cyclin D1 in the IKK␣ Ϫ/Ϫ 3T3 cells and the ability of cyclin D1 overexpression to promote DNA synthesis in fibroblasts (Pagano et al., 1994) , serum-induced DNA synthesis was reduced in IKK␣ Ϫ/Ϫ 3T3 cells ( Figure 6A ). To determine whether the reduction in IKK␣ abundance was important in the reduced levels of cyclin D1, the IKK␣ Ϫ/Ϫ 3T3 cells were transfected with the IKK␣CA expression vector and MACS-sorted, and the cell extracts were subjected to Western blotting. IKK␣ protein levels were increased in the IKK␣CA-transfected IKK␣ Ϫ/Ϫ 3T3 cells ( Figure 6B , lane 3). Although the relative levels of IKK␣ in the IKK␣ Ϫ/Ϫ 3T3 cells transfected with the IKK␣CA expression vector were substantially less than the wt 3T3 cells, cyclin D1 levels were increased threefold compared with the IKK␣ Ϫ/Ϫ 3T3 cells, demonstrating a key role for IKK␣ in inducing cyclin D1 levels. Activity of the cyclin D1 promoter was also increased threefold in IKK␣ Ϫ/Ϫ 3T3 cells transfected with the IKK␣CA expression vector. Furthermore, the induction of cyclin D1 by IKK␣CA required the Tcf site ( Figure 6C ).
To determine whether the activity of other known ␤-catenin responsive promoters were regulated by IKK␣, the relative activity of the c-Myc (He et al., 1998) and Engrailed (McGrew et al., 1999) promoters were compared in the wt and IKK␣ Ϫ/Ϫ 3T3 cells, with relative activity normalized to an internal control of renilla luciferase activity. The relative activity of the Engr and c-Myc promoter activity was reduced 10-to 12-fold in the IKK␣ Ϫ/Ϫ 3T3 cells ( Figure 6D ). Furthermore, as with the cyclin D1 promoter, the serum-induced activity of the Engr promoter was substantially reduced in the IKK␣3T3 cells ( Figure 6D) . Together, these studies demonstrate that the activity of both heterologous and natural Tcf responsive genes is dependent on IKK␣ in vivo. Furthermore, these studies demonstrate an important role for IKK␣ in regulating the kinetics of serum-induced expression of ␤-catenin/Tcf-responsive genes.
IKK␣ Associates with and Phosphorylates ␤-Catenin and Increases ␤-Catenin Abundance
In addition to the differences in Tcf-mediated activation of gene promoters, several lines of evidence suggest that IKK␣ and IKK␤ fulfill distinct cellular functions. Thus, homozygous deletion of the IKK␣ and IKK␤ genes results in distinct phenotypes (Hu et al., 1999 Li et al., 1999a; Takeda et al., 1999) , and IKK␤ acts more potently on IB proteins and plays a more significant role in the NF-B pathway in response to activation with TNF-␣ and IL-1 than IKK␣ Li et al., 1999a Li et al., , 1999b . To investigate further the basis for these diverse functions, we determined the subcellular localization of IKK␣ and IKK␤ and their cell-type expression patterns. Western blot analysis of nuclear and cytoplasmic extracts showed a differential localization of IKK␣ and IKK␤ in Cos-7 cells with IKK␣ present in both the nuclear and cytoplasmic fractions (marked by TFIIB and actin, respectively), whereas IKK␤ was predominantly cytoplasmic ( Figure 6A) , consistent with the immunohistochemical analysis ( Figure 6B ).
Consistent with a role for IKK␣ in regulating ␤-catenin phosphorylation and/or abundance, the total level of wt ␤-catenin and of a higher molecular weight form of ␤-catenin were increased in cells coexpressing IKK␣CA and ␤-catenin expression vectors ( Figure 7A ). Point mutation of ␤-catenin at Ser33 to alanine abrogated the induction of the higher molecular weight form of ␤-catenin (Yost et al., 1996) . The abundance of the ␤-catenin S37A mutant and the higher molecular weight form were also increased in cells transfected with IKK␣CA, suggesting a dominant role for S33 in the generation of the high molecular weight form. Because IKK␣CA induced cyclin D1 and Tcf reporter activity, we hypothesized that IKK␣ may regulate ␤-catenin abundance and/or phosphorylation. In our previous studies, IKK immunoprecipitation on fractionated Cos-7 cell extracts cotransfected with HA-tagged ␤-catenin and FLAG-tagged IKK␣ showed that ␤-catenin is present in IKK␣ immunoprecipitates and IKK␣ was also present in ␤-catenin immunoprecipitates (Lamberti et al., 2001) . We had also demonstrated an association between endogenous ␤-catenin and IKK␣ by reciprocal IP-Western blotting of SW480 cell extracts (Lamberti et al., 2001) . Consistent with these findings in cultured cells, we found that GST-␤-catenin fusion proteins were efficient substrates for phosphorylation by IKK␣ in vitro in which IKK␣ was immunoprecipitated from cultured cells and used as the enzyme source (our unpublished results). The minimal region of ␤-catenin sufficient for phosphorylation by immunoprecipitated IKK␣ included the Nterminal portion of the molecule between aa 30 and 55 (our unpublished results). IKK␣ bound to and phosphorylated ␤-catenin in vitro with an efficiency that was similar to that of IB as recently shown (Lamberti et al., 2001) . Because the IKK␣ immunoprecipitation may coprecipitate other components of the IKK complex to phosphorylate ␤-catenin, IKK␣ was produced in baculovirus, purified, and used as the enzyme source in IKK␣ kinase assays with ␤-catenin as substrate ( Figure 7B ). Purified IKK␣ was sufficient for phosphorylation of GST-␤-catenin 1-400. Deletion of the N-terminus of ␤-catenin (130 -400) abolished phosphorylation by IKK␣, and the N-terminus from 1-91 was sufficient for phosphorylation by IKK␣ ( Figure 7B ). To determine if the endogenous IKK␣ is involved in the phosphorylation of ␤-catenin, equal amounts of proteins from IKK␣ Ϫ/Ϫ and wt MEFs were compared using an antiphospho-␤-catenin antibody. The results shown in Figure 7C demonstrated that phosphorylated ␤-catenin exists in wt MEFs but with a significantly reduced abundance in the IKK␣ Ϫ/Ϫ cells. Interestingly, the levels of the nuclear effector of ␤-catenin, Tcf were also lower in the IKK␣ Ϫ/Ϫ cells. The abundance of the nuclear protein PCNA was similar between the IKK␣ Ϫ/Ϫ and wt MEFs.
Our findings that IKK␣ phosphorylates ␤-catenin and that IKK␣CA increases Tcf activity and ␤-catenin abundance suggests that ␤-catenin phosphorylation by IKK␣ may contribute to the regulation of ␤-catenin-mediated Tcf-dependent gene transcription. The consequent induction of cyclin D1 by PI3K-IKK␣-Tcf signaling contributes to the induction of DNA synthesis.
DISCUSSION
This study demonstrates for the first time a requirement for IKK␣ in response to mitogens and DNA synthesis and the induction thereby of cyclin D1 abundance and promoter activity through a ␤-catenin/Tcf pathway. IKK␣ selectively and directly induced cyclin D1 but not cyclin E or cyclin A. Reintroduction of IKK␣ into IKK␣-deficient cells restored cyclin D1 expression and promoter activity in a Tcf-dependent manner. Using a dominant negative mutant of Tcf activity we showed that IKK␣ induction of cyclin D1 requires ␤-catenin/Tcf activity. IKK␣ was shown to be a key genetic determinant of the activity of several other Tcf responsive genes (c-Myc, Engr, TcfLUC) . IKK␣-deficient cells demonstrated a delayed induction of serum-induced DNA synthesis and a delayed induction of serum-induced activity of the cyclin D1 and Engr promoters. Together these studies indicate a key role for IKK␣ in coordinating the kinetics of mitogen responsiveness to a subset of cellular targets. These studies are consistent with an evolving view that separate components of the IKK complex may subserve distinct functions to convey signal transduction specificity (Ghosh and Karin, 2002) .
Serum induction of DNA synthesis and cyclin D1 expression was PI3K dependent, and cyclin D1 was required for the PI3K-dependent induction of DNA synthesis. PI3K-dependent, serum-induced DNA synthesis was substantially reduced in cyclin D1-deficient cells, indicating a key role for cyclin D1 in this signaling pathway. Although serum deprivation increased apoptosis in cyclin D1 Ϫ/Ϫ MEFs, the inhibition of apoptosis by serum addition was not affected by PI3K inhibition, demonstrating distinct functions of cyclin D1 in PI3K-dependent proliferation versus apoptosis. Although the upstream effectors of IKK␣ that contribute to the induction of ␤-catenin remain to be identified, the current studies demonstrate that the PI3K-dependent induction of cyclin D1 involves IKK␣. PI3K is involved in a PDGF-regulated pathway that activates Akt, leading to an association with and activation of IKK␣ in cultured cells (Romashkova and Makarov, 1999) , which is consistent with a role for PI3K in activating a subset of IKK␣ functions. Although IBindependent effects of Akt on NF-B have been reported (Madrid et al., 2000; Reddy et al., 2000) and IKK␣ phosphorylation by Akt is not essential for IKK activation of NF-B signaling , increasing evidence suggests IKK␣ conveys important kinase-dependent and -independent functions. Because the dominant inhibitors of Akt, IKK␣, and Tcf reduced the induction of cyclin D1 by constitutively active PI3K mutants, it appears that PI3K may be an important upstream inducer of IKK␣ in the context of ␤-catenin/Tcf signaling.
The current studies identify the cyclin D1 Tcf site as the common target of activated PI3K, IKK␣, and ␤-catenin and establish, using dominant negative mutants, a colinearity of these components to regulate cyclin D1 expression in cultured cells. Wnt family ligands and Frizzled family receptors define one important mechanism that can induce ␤-catenin/ Tcf signaling (Polakis, 2000a) . Although until quite recently, the activity of the ␤-catenin/Tcf pathway was thought to be regulated only by Wnts, a substantial body of evidence suggests that important additional regulators of this pathway exist. The protein encoded by Gas6, a growth factor of the vitamin K-dependent family, which binds the Axl receptor of the tyrosine kinase family, stabilizes ␤-catenin and induces Tcf signaling (Goruppi et al., 2001) . Hepatocyte growth factor/scatter factor (Papkoff and Aikawa, 1998) and oncogenic mutations of RON and MET (Danilkovitch-Miagkova et al., 2001 ) all increase cytosolic ␤-catenin and activate Lef/Tcf-responsive reporters. The Xenopus wnt target gene twin is induced by SMAD4 through the ␤-catenin/Tcf complex (Nishita et al., 2000) . In addition, suppressor screens in Drosophila have identified Dpresenilin as a target of Armadillo (a homolog of ␤-catenin; Cox et al., 2000) and a celladhesion-dependent pathway involving the integrin-linked kinase (ILK) was also shown to regulate ␤-catenin levels and activity (Lin and Perrimon, 1999; Payre et al., 1999; Tsuda et al., 1999) . The cyclin D1 gene, which plays a critical role in oncogenic signaling pathways, is regulated (via its Tcf site) by several components that can also regulate ␤-catenin/Tcf signaling. Previous studies have demonstrated a role for the ␤-catenin-Tcf signaling pathway in activation of the cyclin D1 gene by expressing mutants of ␤-catenin, Wnt-1, ILK and repression via presenilin 1 (PS1) or HBP1 (Shtutman et al., 1999; Barker et al., 2000; Lin et al., 2000; Soriano et al., 2001) . Although the cyclin D1 gene is known to be regulated by Tcf signaling, the upstream activators of this pathway were not known. Through identifying the ␤-catenin/Tcf site of the cyclin D1 promoter as a target of PI3K and IKK␣ signaling the current studies provide important evidence for a new signaling pathway that regulates ␤-catenin signaling and cyclin D1 expression.
The reduction of cyclin D1 promoter activity and protein abundance in the IKK␣ Ϫ/Ϫ cells in the current studies, provides genetic evidence for IKK␣ as an inducer of cyclin D1 abundance. Recent studies also provided genetic evidence that this IKK␣ dominant negative mutant inhibits cyclin D1 expression (Cao et al., 2001) . IKK␣ AA knockin mice, in which the IKK␣ catalytic subunit activation loop serines were substituted for alanines, exhibited reduced cyclin D1 abundance in the mammary gland (Cao et al., 2001) . The IKK␣ AA knockin mice failed to develop normal lobular alveolar architecture during pregnancy, and the mammary gland phenotype resembled that of the cyclin D1 Ϫ/Ϫ mice (Cao et al., 2001) , providing further support for a genetic link between IKK␣ and cyclin D1. The current studies are important in identifying cyclin D1 as a direct, rather than an indirect, transcriptional target of IKK␣ and extend these observations by identifying the molecular mechanisms by which IKK␣ directly induces cyclin D1.
Several lines of evidence in the current studies demonstrate a key role for IKK␣ in activating ␤-catenin/Tcf signaling at the cyclin D1 promoter. First, the reduced nuclear Tcf abundance in the IKK␣ Ϫ/Ϫ cells provides genetic evidence supporting an important role for IKK␣ in activating ␤-catenin/Tcf signaling. Second, activating mutants of IKK␣ induced the cyclin D1 promoter significantly (4.7-fold) and induced Tcf activity assessed as an heterologous reporter linked to the luciferase reporter gene. Third, mutation of a single Tcf site at Ϫ81 abrogated induction of the cyclin D1 promoter by either IKK␣ or an activating mutation of ␤-catenin. Together, these studies demonstrate that IKK␣ induces Tcf signaling through this site. In recent studies, IKK immunopreciptiated from cultured cells phosphorylated ␤-catenin as a substrate in vitro (Lamberti et al., 2001) . As IKK immunoprecipitation coprecipitates IKK␣, IKK␤, and IKK␥ (NEMO), these findings raised the important question of whether IKK␣ alone phosphorylated IKK␣.
In the current studies both transfected and endogenous IKK␣ was found in association with ␤-catenin in a variety of cultured cells. A constitutively active form of IKK␣ increased both ␤-catenin abundance and phosphorylation and induced Tcf-dependent transcription. Phosphorylation of ␤-catenin by IKK␣ required the N-terminus of ␤-catenin, and its phosphorylation apparently contributed to the in-crease in ␤-catenin levels. This effect of IKK␣ on ␤-catenin was dependent, at least in part, on the S33 residue of ␤-catenin that has an important role in regulating ␤-catenin stability. The N-terminal domain of ␤-catenin containing these serine residues was sufficient for in vitro phosphorylation and is identical to the domain found in the N-terminus of IB␣ that is phosphorylated by the IKK complex (Aberle et al., 1997 , Orford et al. 1997 . Phosphorylation of serine residues 33 and 37 of ␤-catenin has been implicated in regulating protein stability and signaling by GSK3␤ (Yost et al., 1996) . Mutation of ␤-catenin at S33 abrogated the ability of IKK␣ to induce the higher molecular weight form of ␤-catenin and partially reduced the increase in ␤-catenin levels. Because the IKK␣-dependent phosphorylation of ␤-catenin activated Tcf signaling, this effect most probably represents a different means by which ␤-catenin is regulated either by GSK3␤-␤-TrCP or Siah-1 (Polakis, 2000a) .
Cyclin D1 and ␤-catenin overexpression correlates with poor prognosis in human breast cancer, suggesting a role for cyclin D1 in ␤-catenin/Tcf-mediated signaling and cell transformation (Shtutman et al., 1999; Barker et al., 2000; Lin et al., 2000) . Aberrant activation of the Tcf pathway by mutations in components of the Wnt-signaling pathway is believed to contribute to the development of a variety of human cancers, including colon, breast, and prostate cancer (Polakis, 2000b ). IKK␣ appears to provide an important link to the control of cyclin D1 gene expression through induction of Tcf signaling. Understanding the precise mechanism by which IKK␣ regulates ␤-catenin signaling and the factors specifying IKK activity on ␤-catenin compared with NF-B remains pivotal in determining the signal transduction specificity regulated by these two important pathways.
